Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · Real-Time Price · USD
34.28
+0.39 (1.15%)
Dec 20, 2024, 4:00 PM EST - Market closed
HRMY Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for HRMY stock have an average target of 49.8, with a low estimate of 28 and a high estimate of 75. The average target predicts an increase of 45.27% from the current stock price of 34.28.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for HRMY stock from 10 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 3 | 3 | 4 |
| Buy | 3 | 3 | 3 | 4 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 9 | 9 | 9 | 9 | 9 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $75 | Strong Buy | Initiates | $75 | +118.79% | Dec 17, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $51 → $58 | Buy | Maintains | $51 → $58 | +69.19% | Oct 30, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $56 → $59 | Buy | Reiterates | $56 → $59 | +72.11% | Oct 30, 2024 |
| Needham | Needham | Strong Buy Reiterates $52 | Strong Buy | Reiterates | $52 | +51.69% | Oct 30, 2024 |
| Needham | Needham | Strong Buy Reiterates $52 | Strong Buy | Reiterates | $52 | +51.69% | Oct 29, 2024 |
Financial Forecast
Revenue This Year
726.28M
from 582.02M
Increased by 24.79%
Revenue Next Year
856.87M
from 726.28M
Increased by 17.98%
EPS This Year
2.39
from 2.13
Increased by 12.00%
EPS Next Year
3.25
from 2.39
Increased by 36.18%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 753.1M | 934.3M | 1.2B | |||
| Avg | 726.3M | 856.9M | 1.0B | |||
| Low | 691.9M | 774.9M | 799.4M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 29.4% | 28.6% | 38.6% | |||
| Avg | 24.8% | 18.0% | 19.6% | |||
| Low | 18.9% | 6.7% | -6.7% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 2.71 | 4.37 | 6.32 | |||
| Avg | 2.39 | 3.25 | 4.66 | |||
| Low | 2.07 | 1.78 | 3.13 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 27.2% | 83.1% | 94.6% | |||
| Avg | 12.0% | 36.2% | 43.5% | |||
| Low | -2.9% | -25.2% | -3.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.